View drug registration information details.
Items | Registration information |
ID | 269 |
No | 269 |
Brand Name | AZIMAX-250 |
Ingredients | AZITHROMYCIN DIHYDRATE 262.05 MG EQ.TO AZITHROMYCIN 250 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 25 C, PROTECT FROM MOISTURE |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 1 X 6'S, 5 X 6'S |
Dispensing Category | Prescription only |
ATC Classification | J01FA10 |
Pharmaceutical Class | ANTIBACTERIA |
Indications | BRONCHITIS, COMUNITY-ACQUIRED PNEUMONIA, SINUSITIS, PHARYNGITIS/TONSILITIS, OTITIS MEDIA, SKIN AND SOFT TISSUE INFECTION, UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS |
Contraindications | HYPERSENSITIVITY, RISK-BENEFIT SHOULD BE CONSIDERD WHEN HEPATIC FUNCTION IMPAIREMENT EXISTS BECAUSE BILLIARY EXCRETION IS THE MAJOR ROUTE OF ELIMINATION |
Side Effects | GASTROINTESTINAL DISTURBANCE, TRANSIENT ELEVATIONS OF LIVER ENZYME VALUES, CHOLESTATIC JAUNDICE, RASHES, HEADACHE, DIZZINESS, TRANSIENT ALTERATIONS IN NEUTROPHIL |
Unit Price | 1.63 |
EDL |
Yes |
Description | OBLONG, WHITE FILM-COATED TABLET, BEVEL-EDGED, SHALLOW CONVEX WITH BREAK-BAR ON ONE SIDE AND HOVID EMBOSSED ON THE OTHER SIDE |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL11090011AZ |
Import Registration Date | 27/09/2016 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-04-08 |
FDD Registration No | 04 I 4686/19 |
FDD Registration Date | 2022-09-08 |
Expiry Date | 2025-09-07 |
Back to drug list
|